VIE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/03/2026 15:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeVIE
Market Capitalization14,084 mln
Float29.97 mln
Earnings Date07/31/2026
EPS
6.19
Strong
P / E
25.90
Elevated
Piotroski F-Score
8
/ 9
Very strong
Beneish M-Score
-2.92
Likely reliable
Relative Strength
25
/ 100
Underperforming
Debt / Equity
0.20
Very low leverage
Business Description
Founded in 1929 and based in Paris, France, Ipsen is a global biopharmaceutical company focused on developing and selling treatments for cancer, rare diseases, and neurological conditions across North America, Europe, and beyond. Its portfolio includes established medicines targeting conditions such as prostate cancer, neuroendocrine tumors, and movement disorders, alongside newer therapies addressing rare liver diseases and abnormal bone growth. The company also maintains an active pipeline of clinical-stage treatments being studied for blood cancers, brain tumors, and other serious conditions.
